- Home
- TCMD
as of 02-27-2026 3:39pm EST
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 300.1M | IPO Year: | 2016 |
| Target Price: | $36.00 | AVG Volume (30 days): | 383.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.82 | EPS Growth: | 17.14 |
| 52 Week Low/High: | $8.61 - $37.77 | Next Earning Date: | 05-19-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 7.7% | Revenue Growth (next year): | 8.79% |
| P/E Ratio: | 36.35 | Index: | N/A |
| Free Cash Flow: | 40.4M | FCF Growth: | +5.67% |
AI-Powered TCMD Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Tactile Systems Technology Inc. (TCMD)
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.94
Shares
6,246
Total Value
$180,764.24
Owned After
82,581
SEC Form 4
CHIEF FINANCIAL OFFICER
Avg Cost/Share
$28.94
Shares
7,701
Total Value
$222,880.03
Owned After
134,819
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$28.94
Shares
10,993
Total Value
$318,144.02
Owned After
243,885
SEC Form 4
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.49
Shares
4,439
Total Value
$125,611.96
Owned After
82,581
CHIEF FINANCIAL OFFICER
Avg Cost/Share
$28.49
Shares
5,518
Total Value
$156,143.61
Owned After
134,819
Chief Executive Officer
Avg Cost/Share
$28.49
Shares
15,240
Total Value
$431,245.11
Owned After
243,885
Sr. VP Mktg & Clinical Affairs
Avg Cost/Share
$28.85
Shares
5,139
Total Value
$148,260.15
Owned After
82,581
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 24, 2026 | Sell | $28.94 | 6,246 | $180,764.24 | 82,581 | |
| Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Feb 24, 2026 | Sell | $28.94 | 7,701 | $222,880.03 | 134,819 | |
| Dodd Sheri Louise | TCMD | Chief Executive Officer | Feb 24, 2026 | Sell | $28.94 | 10,993 | $318,144.02 | 243,885 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Feb 23, 2026 | Sell | $28.49 | 4,439 | $125,611.96 | 82,581 | |
| Birkemeyer Elaine M. | TCMD | CHIEF FINANCIAL OFFICER | Feb 23, 2026 | Sell | $28.49 | 5,518 | $156,143.61 | 134,819 | |
| Dodd Sheri Louise | TCMD | Chief Executive Officer | Feb 23, 2026 | Sell | $28.49 | 15,240 | $431,245.11 | 243,885 | |
| Burns Kristie | TCMD | Sr. VP Mktg & Clinical Affairs | Jan 2, 2026 | Sell | $28.85 | 5,139 | $148,260.15 | 82,581 |
Compare TCMD vs Leading Stocks
See how TCMD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TCMD Tactile Systems Technology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.